Wednesday, January 22, 2020
Home 2019 November

Monthly Archives: November 2019

Mitesco, Biotech Stock Review
Incubator

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic...

Editor / Curator -
Biotech News

Frontier Bio (FBIO) Bolstering it’s Warchest.

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Incubator

Is True Nature (TNTY) $0.04, Nearing a Breakout?

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Accelerator

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Editor / Curator -
biogen, biotech stock review
Biotech News

Biotech’s Turning Up…

Editor / Curator -
True Nature, Biotech Stock Review
Accelerator

True Nature | Mitesco (TNTY), Perking Up.

Editor / Curator -
Dyadic, Biotech Stock Review
Biotech News

Dyadic (DYAI) Highlights.

Editor / Curator -
Mustang Bio, Biotech Stock Review
Biotech News

Mustang Bio (MBIO) Highlights.

Editor / Curator -
Accelerator

Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...

Editor / Curator -
Internet News

IDEALAB. First Mover, Last Survivor.

Editor / Curator -
12Page 1 of 2

Latest article

Oramed, Biotech Stock REview

Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?

Biotech News Editor / Curator -
New technology could revolutionize market of 500 million diabetes patients (i24 News).
Mitesco, Biotech Stock Review

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.

Incubator Editor / Curator -
True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors.
video

Candida Auris: Hospitals mobilize to fight the deadly infection (Video). More Videos Below.

Biotech News Editor / Curator -
https://youtu.be/hnqFdKSG6-A Auris all over the room, even on the ceiling?.
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.